The risk of ovarian cancer in BRCA1 and BRCA2 mutation patients is 44% and 17%, respectively, whereas the lifetime risk of breast cancer is up to 72% in these patients.39 This evidence concerns the gene BRCA1 and ovarian carcinoma.